Presentations highlight AI-driven mRNA design process enabling up to 40-fold selectivity and 10-fold in vivo oncoselectivity ...
Scientists from a German-Swiss consortium have developed miniature antibody-like proteins, called DARPins, that can stabilize and reactivate multiple mutated forms of the p53 tumor suppressor protein ...
In vitro transcribed mRNA has lived up to its potential as a game-changing disruptive vaccine modality during the COVID-19 ...
Cells manufacture proteins by following instructions encoded in messenger RNA, which is read in three-letter groups called ...
Morning Overview on MSN
Study finds injured skin cells rapidly ramp up protein-making hubs
When you nick your finger slicing vegetables, the outer layer of your skin starts patching itself within minutes. A study ...
In this valuable study, the authors develop new approaches to investigate mRNA imprinting, a phenomenon in which RNA-protein complexes form in the nucleus to influence the fate of transcripts in the ...
CREATE Medicines, Inc. ("CREATE"), a clinical-stage biotechnology company pioneering in vivo immune cell programming, today ...
Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily PharmaVoice ...
Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution. Researchers ...
In the article by He and Zhu, “Selective mRNA Translation: A New Player in Ferroptosis After Myocardial Infarction” which appeared in the January 20, 2026, issue of the journal (Circulation.
This important study provides evidence for dynamic coupling between translation initiation and elongation that can help maintain low ribosome density and translational homeostasis. The authors combine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results